ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells
Maowu Luo, Weibo Luo(Southwestern Medical Center), Jennifer E. Wang(Southwestern Medical Center), Yingfei Wang(Southwestern Medical Center), Ashwani Kumar(Government Medical College), Chase D. Corley(Southwestern Medical Center), Bo Zhang(Shanghai University of Traditional Chinese Medicine), Yan Chen(Guiyang Medical University), Yong Wang(Southwestern Medical Center), Lei Bao(Peking University), Chao Xing(Southwestern Medical Center), Chenliang Wang(Southwestern Medical Center), Yuanyuan Xue(Chinese Academy of Sciences), Jeffrey G. McDonald(The University of Texas Southwestern Medical Center), Yisheng Fang(Southwestern Medical Center), Erik R. Nelson(University of Illinois Urbana-Champaign)
Cited by 36
Related Papers
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses
|Cell|2012|598
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
|Hepatology|2014|529
Low shifts in salinity determined assembly processes and network stability of microeukaryotic plankton communities in a subtropical urban reservoir
|Microbiome|2021|457
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
|Nature Communications|2017|420